Updated: January 9, 2026
Lynparza Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
- Common Lynparza Side Effects (Occur in 10% or More of Patients)
- Serious Side Effects: Call Your Doctor Immediately If You Notice These
- 1. Signs of MDS or Acute Myeloid Leukemia (AML)
- 2. Pneumonitis (Lung Inflammation)
- 3. Venous Thromboembolism (Blood Clots)
- 4. Embryo-Fetal Toxicity
- What Monitoring Is Required While on Lynparza?
- Getting Your Lynparza Prescription Filled
Nausea, fatigue, and anemia are the most common Lynparza side effects. Learn what to expect, how to manage them, and which symptoms mean you need to call your doctor now.
Starting Lynparza (olaparib) can feel daunting if you're not sure what side effects to expect. The good news: most patients tolerate Lynparza reasonably well, and many side effects are manageable with supportive care. That said, there are serious side effects that require immediate medical attention. This guide walks you through both.
Common Lynparza Side Effects (Occur in 10% or More of Patients)
These are the most frequently reported side effects from Lynparza clinical trials, primarily in ovarian cancer maintenance studies:
Nausea — The most common side effect. Mild to moderate nausea is very common, especially in the first few weeks. Taking Lynparza with food may help. Your doctor can prescribe antiemetics if needed.
Fatigue and asthenia (weakness) — Very common. Often improves with time. Rest when needed, and let your oncology team know if it's significantly affecting your daily life.
Anemia (low red blood cells) — Common and can worsen fatigue. Your blood counts are monitored regularly; dose adjustments or transfusions may be needed in some cases.
Vomiting — Related to nausea; antiemetics can help. Staying hydrated is important.
Diarrhea — Manageable with dietary adjustments. Avoid high-fiber and fatty foods during flares. Tell your doctor if it's severe or persists.
Decreased appetite — Eating smaller, frequent meals can help. A registered dietitian on your oncology team may have additional suggestions.
Headache and dizziness — Usually mild. Stay hydrated and avoid driving if you feel dizzy.
Dysgeusia (taste changes) — Food may taste different or metallic. This usually improves with time.
Cough and shortness of breath (dyspnea) — Mild respiratory symptoms are relatively common. Severe or worsening shortness of breath needs prompt evaluation (see serious side effects below).
Neutropenia, leukopenia, thrombocytopenia — Low white blood cells and platelets. Monitored with monthly blood counts; may require dose reduction.
Serious Side Effects: Call Your Doctor Immediately If You Notice These
1. Signs of MDS or Acute Myeloid Leukemia (AML)
Myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) occurred in approximately 1.2% of patients across Lynparza clinical studies. The majority of these cases were fatal. Warning signs include:
Unusual bruising or bleeding
Persistent or severe fatigue beyond your baseline
Frequent infections
Significant changes in blood count results (flagged by your regular monitoring)
This is why monthly blood count monitoring is mandatory. If MDS or AML is confirmed, Lynparza must be discontinued.
2. Pneumonitis (Lung Inflammation)
Lynparza can cause inflammation in the lungs (pneumonitis). Symptoms include:
New or worsening cough
Shortness of breath or difficulty breathing that is new or worsening
Fever
If pneumonitis is confirmed, Lynparza must be permanently discontinued. Call your doctor immediately—do not wait for your next scheduled appointment.
3. Venous Thromboembolism (Blood Clots)
Lynparza may cause blood clots in the veins (DVT) or lungs (pulmonary embolism). Seek emergency care immediately if you experience:
Sudden chest pain or pressure
Sudden shortness of breath
Swelling, redness, or pain in one leg (especially the calf)
Rapid heartbeat
4. Embryo-Fetal Toxicity
Lynparza can cause serious harm to an unborn baby. If you are a woman of childbearing potential, you must use effective contraception during treatment and for 6 months after your last dose. Male patients with female partners should use contraception during treatment and for 3 months after. Do not breastfeed during Lynparza treatment or for 1 month after the last dose.
What Monitoring Is Required While on Lynparza?
Complete blood count (CBC) at baseline and monthly throughout treatment
Report any new respiratory symptoms promptly
Pregnancy test before starting in women of reproductive potential
Getting Your Lynparza Prescription Filled
If you're managing side effects and also dealing with difficulty filling your prescription, medfinder can help locate a specialty pharmacy near you that has Lynparza in stock—so you can focus on your health, not pharmacy logistics.
See also: Lynparza Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
The most common Lynparza side effects (occurring in 10% or more of patients) are nausea, fatigue, anemia, vomiting, diarrhea, decreased appetite, headache, taste changes (dysgeusia), cough, neutropenia, shortness of breath, dizziness, and low platelets (thrombocytopenia). Most are manageable with supportive care and dose adjustments.
Hair loss (alopecia) is not listed among the most common (≥10%) adverse reactions in Lynparza clinical trials. Nausea, fatigue, and anemia are much more commonly reported. However, individual experiences vary—ask your oncologist if you're concerned about this specific side effect.
MDS or AML occurred in approximately 1.2% of patients in Lynparza clinical studies, and the majority of these cases were fatal. This is why monthly blood count monitoring is required. The risk appears highest in patients who received prior platinum-based chemotherapy. If MDS/AML is confirmed, Lynparza must be permanently discontinued.
For Lynparza-related nausea: take tablets with food, eat smaller and more frequent meals, avoid strong smells, and stay hydrated. If nausea is severe or interfering with daily activities, contact your oncologist—they may prescribe antiemetic medications such as ondansetron or metoclopramide.
Never stop Lynparza without consulting your oncologist. Dose reductions (to 250 mg or 200 mg twice daily) are standard management for most side effects. Lynparza must be permanently discontinued if MDS/AML or pneumonitis is confirmed. Call your doctor immediately for any new respiratory symptoms, severe blood count changes, or signs of blood clots.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Lynparza also looked for:
More about Lynparza
32,900 have already found their meds with Medfinder.
Start your search today.





